NGL Fine-Chem (BOM:524774) Net Income From Continuing Operations : ₹413 Mil (TTM As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is NGL Fine-Chem Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. NGL Fine-Chem's net income from continuing operations for the three months ended in Mar. 2024 was ₹123 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ₹413 Mil.

NGL Fine-Chem Net Income From Continuing Operations Historical Data

The historical data trend for NGL Fine-Chem's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NGL Fine-Chem Net Income From Continuing Operations Chart

NGL Fine-Chem Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Income From Continuing Operations

Get a 7-Day Free Trial

120.72

775.90

665.97

273.62

544.17

NGL Fine-Chem Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															89.86	85.07	104.78	100.34	122.98

NGL Fine-Chem Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹413 Mil.

NGL Fine-Chem (BOM:524774) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NGL Fine-Chem Ltd (BOM:524774) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

NGLFINE:India

Address

301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057

Website

https://www.nglfinechem.com

NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. The company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Its product includes Active Pharmaceutical Ingredients (APIs) animal health, APIs human health, Intermediates and Finished dosage form, of which maximum revenue is generated from Veterinary APIs. Its geographical segments include India, Europe, Asia Pacific, United States, and Rest of the world. The Group's business activities fall within a single business segment of pharmaceuticals.

NGL Fine-Chem (BOM:524774) Headlines

No Headlines